Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Penson

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|November 5, 2024
Reaping the rewards of a simplified dosing regimenPeter E Penson, Maciej Banach
European Journal of Preventive Cardiology|February 24, 2021
Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemiaMaciej Banach, Peter E Penson
European Journal of Preventive Cardiology|August 14, 2019
Genetic testing in familial hypercholesterolaemia: What does it add?Maciej Banach, Peter E Penson
Current Atherosclerosis Reports|May 10, 2021
Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent StudiesMaciej Banach, Peter E Penson
European Heart Journal Open|November 28, 2022
Adherence to statin therapy: it seems we know everything, yet we do nothingMaciej Banach, Peter E Penson
Cardiovascular Research|January 4, 2019
What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER?Maciej Banach, Peter E Penson
Current Atherosclerosis Reports|September 18, 2020
The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with DyslipidaemiaPeter E Penson, Maciej Banach
Atherosclerosis|December 19, 2020
Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomesPeter E Penson, Maciej Banach
Expert Opinion on Biological Therapy|May 21, 2024
Could siRNA therapeutics change the way we treat dyslipidemia?Peter E Penson, Alice P McCloskey
Expert Review of Clinical Pharmacology|July 27, 2023
Therapeutic drug monitoring: applying the 'Goldilocks Principle' to clinical pharmacologyPeter E Penson, Alice P McCloskey
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
European Heart Journal. Cardiovascular Pharmacotherapy|November 5, 2024
Reaping the rewards of a simplified dosing regimenPeter E Penson, Maciej Banach
European Journal of Preventive Cardiology|February 24, 2021
Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemiaMaciej Banach, Peter E Penson
European Journal of Preventive Cardiology|August 14, 2019
Genetic testing in familial hypercholesterolaemia: What does it add?Maciej Banach, Peter E Penson
Current Atherosclerosis Reports|May 10, 2021
Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent StudiesMaciej Banach, Peter E Penson
European Heart Journal Open|November 28, 2022
Adherence to statin therapy: it seems we know everything, yet we do nothingMaciej Banach, Peter E Penson
Cardiovascular Research|January 4, 2019
What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER?Maciej Banach, Peter E Penson
Current Atherosclerosis Reports|September 18, 2020
The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with DyslipidaemiaPeter E Penson, Maciej Banach
Atherosclerosis|December 19, 2020
Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomesPeter E Penson, Maciej Banach
Expert Opinion on Biological Therapy|May 21, 2024
Could siRNA therapeutics change the way we treat dyslipidemia?Peter E Penson, Alice P McCloskey
Expert Review of Clinical Pharmacology|July 27, 2023
Therapeutic drug monitoring: applying the 'Goldilocks Principle' to clinical pharmacologyPeter E Penson, Alice P McCloskey
Pageof 10